Du Y, Qi Z, Liang X, et al. Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study . Dermatol Pract Concept. 2024;14(1):e2024026. doi:10.5826/dpc.1401a26